Definition of minimal disease activity in psoriasis-Reference-Cited by-同舟云学术

Definition of minimal disease activity in psoriasis

Published:2020-07-28 Issue:2 Volume:35 Page:422-430
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Carretero G.¹,Carrascosa J.M.²^ORCID,Puig L.³^ORCID,Sánchez‐Carazo J.L.⁴,López‐Ferrer A.³,Cueva P.⁵,Soria C.⁶,Rivera R.⁷^ORCID,Belinchón I.⁸^ORCID,

Affiliation:

1. Hospital Universitario de Gran Canaria Doctor Negrín Las Palmas de Gran Canaria Spain

2. Hospital Universitario Germans Trias i Pujol Badalona, Barcelona Spain

3. Hospital de la Santa Creu i Sant Pau Barcelona Spain

4. Hospital General Universitario de Valencia Valencia Spain

5. Hospital Universitario Infanta Leonor Madrid Spain

6. Hospital General Universitario Reina Sofía de Murcia Murcia Spain

7. Hospital Universitario 12 de Octubre Madrid Spain

8. Hospital General Universitario de Alicante Alicante Spain

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16564

Reference45 articles.

1. WHO Global report Psoriasis corrected 4‐2016_eng. [WWW document]2006. URLhttps://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.pdf?sequence=1&isAllowed=y(last accessed: 01 January 2020).

2. Psoriasis: to treat or to manage?

3. Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States

4. Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

5. Strategies for improving the quality of care in psoriasis with the use of treatment goals - a report on an implementation meeting

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [Translated article] Study of the Impact of Restrictions on Access to Biological Drugs for the Management of Psoriasis on the Minimum Disease Activity Criteria: Subanalysis of AEDV EQUIDAD and AME Projects;Actas Dermo-Sifiliográficas;2024-08

2. 52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience;Actas Dermo-Sifiliográficas;2024-07

3. [Artículo traducido] Eficacia a medio plazo (52 semanas) de tildrakizumab en el tratamiento de la psoriasis moderada a severa: un estudio multicéntrico de práctica clínica;Actas Dermo-Sifiliográficas;2024-07

4. Valoración de la medida de Actividad Mínima de Enfermedad en Psoriasis en España: estudio transversal nacional;Actas Dermo-Sifiliográficas;2024-06

5. Estudio del impacto de las restricciones en el acceso a fármacos biológicos en psoriasis sobre la actividad mínima de la enfermedad: subanálisis de los proyectos EQUIDAD y AME de la AEDV;Actas Dermo-Sifiliográficas;2024-05